View of PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING OF LONG-ACTING CABOTEGRAVIR AND RILPIVIRINE IN SPECIAL POPULATIONS AND DRUG–DRUG INTERACTION SCENARIOS

Return to Article Details PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING OF LONG-ACTING CABOTEGRAVIR AND RILPIVIRINE IN SPECIAL POPULATIONS AND DRUG–DRUG INTERACTION SCENARIOS Download Download PDF